Autori: Andric Zoran G
| Naslov | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial (Article) |
| Autori | Reck Martin ... Andric Zoran G  ... (broj koautora 18)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2024), vol. 19 br. 2, str. 297-313 |
| Projekat | Healthcare business of Merck KGaA, Darmstadt, Germany; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
     |
| Naslov | Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 20)
|
| Info | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, (2024), vol. 118 br. 1, str. E9-E10 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study. (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 17_SUPPL, Suppl. 17_, str. LBA9005-LBA9005 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 25)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S96-S97 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results (Meeting Abstract) |
| Autori | Liu SV ... Andric Zoran G ... (broj koautora 24)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S44-S45 |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G Petrovic Z Nagarkar R Chawla T Chong LO Nixon B Yavrom S Ede NJ Wiedermann Ursula
|
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S864-S864 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study (Meeting Abstract) |
| Autori | Kotecha R ... Andric Zoran G ... (broj koautora 20)
|
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. - |
| Projekat | Novocure |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study (Article) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 25)
|
| Info | LANCET ONCOLOGY, (2023), vol. 24 br. 9, str. 1002-1017 |
| Projekat | Novocure |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 17, Suppl. S, str. - |
| Projekat | Novocure |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G Petrovic Zeljko M Nagarkar R Chawla T Chong LMO Nixon B Yavrom S Ede NJ Wiedermann Ursula
|
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 1, str. S4-S4 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
